Refine by
Applications
- Bioinformatics software solutions for single cell rna-seq sector
- Bioinformatics software solutions for gene expression sector
- Bioinformatics software solutions for variant detection sector
- Bioinformatics software solutions for CNV analysis sector
- Bioinformatics software solutions for metagenomics sector
Assay Software In North America
16 software items found
by:Novatek International based inMontreal, QUEBEC (CANADA)
Many business units within pharmaceutical, biotechnology and clinical research organizations must comply with federal regulations concerning their processes and computerized systems. One of the most challenging processes throughout clinical studies is the creation and management of assay plans and tracking assay ...
Premium
Manufactured by:AB Sciex LLC based inFramingham, MASSACHUSETTS (USA)
The IVD LC-MS/MS Software That Gives You Simple Automated Analysis from Sample to Report. With more samples to be analyzed in shorter timeframes, clinical laboratories need instrumentation and software that streamlines the process of performing routine mass spectrometry ...
by:Partek Incorporated based inChesterfield, MISSOURI (USA)
It is fast, agile, and memory efficient. With a user-friendly interface, rich visualizations, and guided workflows for common genomics assays, Partek Genomics Suite gives biologists, bioinformaticists, and statisticians a single, integrated solution for trustworthy ...
Manufactured by:Fusion Genomics Corporation based inBurnaby, BRITISH COLUMBIA (CANADA)
It is a secure and compliant bioinformatics platform for sensitive and multiplexed pathogen identification from (NGS) data generated by the ONETest molecular diagnostic assay ...
Manufactured by:LI-COR Biotech, LLC based inLincoln, NEBRASKA (USA)
It improves data integrity by ensuring repeatable scans critical for quantitative research, especially in applications like Western blots, whole slide imaging, and in-cell Western assays. This software also features improved compatibility with 21 CFR Part 11 compliance for enhanced regulatory adherence, supporting a wide range of research applications in laboratories ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Push the boundaries of your in-house liquid biopsy capabilities with MSK-ACCESS® powered with SOPHiA DDM™, a decentralized version of the rigorously validated cell-free DNA (cfDNA) assay developed and used in clinical routine by Memorial Sloan Kettering Cancer Center (MSK)1,2. Discover an innovative solution that combines MSK’s expertise in cancer genomics with ...
Manufactured by:Agilent Technologies, Inc. based inSanta Clara, CALIFORNIA (USA)
The SureSelect Focused Exome is a highly targeted design that enables analysis of only the disease-associated targets providing deep coverage even on a benchtop sequencer. This design provides 20 or more reads for 95% of targets at 1.5Gb (100x) of sequencing and 98% of targets with 3Gb (200x) of sequencing enabling superior coverage of disease-associated regions even when sequenced on benchtop ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Metabolic disorders are a major cause of morbidity and mortality, representing a growing health concern worldwide. Over the last decade, substantial progress has been made in the discovery of genetic variants influencing a range of metabolic diseases.1 The advances in next generation sequencing (NGS) technologies have contributed to elucidation of the pathogenic role of variants associated with ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Cardiac diseases are the #1 cause of death globally1,2. Genetic testing is frequently considered a key component of the clinical management process of inherited cardiac disorders, such as hypertrophic, dilated, and arrhythmogenic cardiomyopathies, aortopathies, and inherited arrhythmia syndromes3. This approach is typically reserved for patients with a confirmed or suspected diagnosis of an ...
by:Progentec Diagnostics, Inc. based inOklahoma City, OKLAHOMA (USA)
Immunological insights for proactive lupus care; Get started today with aiSLE DX Flare Risk Index, a new blood test that identifies a SLE patient's future risk of a lupus ...
by:Flagship Biosciences Inc. based inBroomfield, COLORADO (USA)
Your next pathology-based CDx starts here. With the complexity of therapies increasing, the need for a robust companion diagnostic (CDx) has never been higher. Advances in tissue analysis technologies now require a more quantitative, accurate, and precise pathology-based CDx. Bringing your CDx to market requires a solid strategy to meet strict regulatory standards and critical timelines. Your CDx ...
by:CareDx, Inc based inSouth San Francisco, CALIFORNIA (USA)
Every minute of laboratory time is valuable. AlloSeq HCT can help you save time with a simple workflow and powerful analysis software, all while achieving high sensitivity chimerism monitoring. Engraftment monitoring (chimerism) testing evaluates the success of a hematopoietic stem cell transplant by measuring the relative ratio of the recipient and the donor cell population in the ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
HALO AP brings case-centric digital pathology slide management, collaboration, and quantitative analysis to your Anatomic Pathology lab. The browser-based HALO AP interface provides anywhere, anytime access to digital slides for remote sign-out, secondary consultations as well as quantitative IHC workflows. With LIS/LIMS integration, multiple deployment options and end-to-end implementation ...
by:Eidogen-Sertanty, Inc. based inOceanside, CALIFORNIA (USA)
The Oncology Knowledgebase (OKB) is Eidogen-Sertanty's database of structure-activity data across numerous targets of oncological interest. Nicely complementing the Kinase Knowledgebase (KKB), the OKB will cover a broad spectrum of targets relevant to Colon cancer, Esophageal cancer, Glioma, Head and Neck cancer, Kidney cancer, Leukemia, Liver cancer, Lung cancer, Lymphoma, Melanoma, Ovarian ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Pioneering Innovation, Streamlining Adoption: We are pushing the boundaries of today’s liquid biopsy capabilities. Bring liquid biopsy to your lab with our streamlined DNA-only NGS workflow, taking you from cell-free DNA sample to comprehensive report in record time. Powered by state-of-the-art proprietary algorithms, the SOPHiA DDMTM Platform reveals deep genomic insights from cell-free ...
by:Cypre, Inc. based inSan Francisco, CALIFORNIA (USA)
Cypre’s 3D Tumor Models combine the tumor, stromal and immune compartments in a high throughput format to screen targeted drugs and immunotherapy. In 2021, we partnered with Charles River to offer our 3D Tumor Models for drug discovery and preclinical screening services. Cypre Panels rapidly screen small molecules, biologics and cell therapy in 3D hydrogel in vitro tumor models. ...